Business
Marketing and Distribution We distribute our products internationally predominantly through a network marketing system, which is a form of person-to-person direct selling.
NATURAL HEALTH TRENDS CORP: Revenue declined 7.4% to $39.78M from $42.96M. Net income turned into a $882K loss from $572K of profit. Free cash flow outflow widened to $6.065M from $3.424M. Operating margin contracted 153 bps to -4.55%. NATURAL HEALTH TRENDS CORP's annual comparison also shows capital spending grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 7.4% to $39.78M from $42.96MWatch
- Profitability — Net income turned into a $882K loss from $572K of profitWatch
- Cash flow — Free cash flow outflow widened to $6.065M from $3.424MWatch
- Margins — Operating margin contracted 153 bps to -4.55%Watch
- Accounting — Distress-range screen needs contextWatch
- Insiders — 0 purchases and 0 salesNote
Where the revenue comes from
Fiscal 2025, as NATURAL HEALTH TRENDS CORP reports it. History and quarterly detail are in the app.
- Primary Reporting$38.4M
- China$946K
- Russia and Kazakhstan$444K
Latest filings
- 10-Q · Quarterly report2026-07-29
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-05-07
- 10-Q · Quarterly report2026-04-29
- 8-K · Company announcement2026-04-29
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about NATURAL HEALTH TRENDS CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.